Innate Pharma (France)

Innate Pharma (France)

Open Access statistics for Innate Pharma (France), France, covering academic research published from 2000 to 2023.

Open Access statistics for Innate Pharma (France), France, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

62%


Total
Publications

504


Total Open
Publications

314


Total
Citations

27K


Open Access
Percentage

62%


Total
Publications

504


Total Open
Publications

314


Total
Citations

27K

Website

download

Breakdown

20% 30% 12% 38%

Publisher Open

20%

Both

30%

Other Platform Open

12%

Closed

38%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0510152025303540455055Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

27%OA Journal

OA Journal 27%

69

Hybrid 30%

76

No Guarantees 43%

110

Other Platform Open

Domain 77%

164

Institution 46%

98

Other Internet 19%

41

Public 8%

17

Preprint 8%

16

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
161
Europe PMC
Domain
100
Le Centre pour la Communication Scientifique Directe - HAL - Aix-Marseille Université
Institution
42
Le Centre pour la Communication Scientifique Directe - HAL - Université Paris Descartes
Institution
28
Le Centre pour la Communication Scientifique Directe - HAL - Université de Nantes
Institution
28
Le Centre pour la Communication Scientifique Directe - HAL - Inria
Institution
27
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
26
Le Centre pour la Communication Scientifique Directe - HAL - memSIC
Other Internet
24
Le Centre pour la Communication Scientifique Directe - HAL - Inserm
Institution
12
Semantic Scholar
Public
10
1 / 9

Data updated 13 August 2024

Share

Share

Share